<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00256048</url>
  </required_header>
  <id_info>
    <org_study_id>2002.228</org_study_id>
    <nct_id>NCT00256048</nct_id>
  </id_info>
  <brief_title>Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients.</brief_title>
  <official_title>Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Melbourne Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Melbourne Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if naso-jejunal feeding (feeding beyond the&#xD;
      stomach) improves the efficacy of enteral feeding (feeding into the gut) in critically ill&#xD;
      patients.&#xD;
&#xD;
      The study hypothesis is that in patients who fail to establish enteral feeding via the&#xD;
      nasogastric route, introduction of nasojejunal feeding will lead to more effective enteral&#xD;
      feeding than the current regime involving staged introduction of promotility agents.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study examines the area of enteral feeding in critically ill patients. Current standard&#xD;
      enteral feeding practice is via a nasogastric with the addition of promotility agents for&#xD;
      patients who fail to absorb their enteral nutrition.&#xD;
&#xD;
      This study compares the efficacy of nasojejunal feeding feeding with nasogastric enteral&#xD;
      feeding with the addition of promotility agents.&#xD;
&#xD;
      The duration of feeding will be determined by the patients nutritional requirements and their&#xD;
      general condition. However the data will be collected for duration of enteral feeding, 28&#xD;
      days or ICU discharge whichever occurs first.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2003</start_date>
  <completion_date type="Actual">July 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of feeding</measure>
    <time_frame>participants will be followed until death, discharge from ICU, commencement of oral or parental nutrition or 28 days post ICU admission</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>1. To determine the incidence of complications with enteral feeding via nasogastric and nasojejunal routes.</measure>
    <time_frame>participants will be followed until death, discharge from ICU, commencement of parental or oral nutrition or 28 days post ICU admission.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2. To assess the efficacy of current strategies for optimising enteral feeding efficacy.</measure>
    <time_frame>participants will be followed until death, discharge from ICU commencement of oral or parental nutrition,or 28 days post ICU admission.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Critically Ill</condition>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive enteral nutrition via a nasogastric tube as per standard feeding regime</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasojejunal Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will receive feeding via a nasojejunal feeding tube</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nasojejunal feeding</intervention_name>
    <arm_group_label>Nasojejunal Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adult patients (18years or over) admitted to the ICU with an expected stay of more&#xD;
             than 48 hours.&#xD;
&#xD;
          2. Patients commenced on enteral feeding via a nasogastric tube who fail to tolerate&#xD;
             gastric feeding due to excessive gastric aspirate volumes.&#xD;
&#xD;
          3. Patients who consent or if the patient is incompetent, the next of kin, who consent,&#xD;
             to inclusion in the study.&#xD;
&#xD;
             -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. patients less than 18 years of age.&#xD;
&#xD;
          2. Patients with known allergy to promotility agents, metoclopramide or erythromycin.&#xD;
&#xD;
          3. Patients with a contra indication to nasojejunal feeding. -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Megan Robertson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intensive Care Unit, Royal Melbourne Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Intensive Care Unit, Royal Melbourne Hospital, Grattan Street</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <zip>3050</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <study_first_submitted>November 17, 2005</study_first_submitted>
  <study_first_submitted_qc>November 17, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2005</study_first_posted>
  <last_update_submitted>April 10, 2017</last_update_submitted>
  <last_update_submitted_qc>April 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <organization>Melbourne Health</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

